Loading...
HomeMy WebLinkAbout7.12.22 Board Correspondence - FW_ New Comirnaty labeled “vaccine” From:Paulsen, Shaina To:Pickett, Andy; Stephens, Brad J.; Valencia, Shyanne; Reaster, Kayla Subject:Board Correspondence - FW: New Comirnaty labeled “vaccine” Date:Tuesday, July 12, 2022 8:54:30 AM Shaina Paulsen Associate Clerk of The Board Butte County Administration 25 County Center Drive, Suite 200, Oroville, CA 95965 T: 530.552.3304 | F: 530.538.7120 -----Original Message----- From: lance dreiss <lancedreiss@att.net> Sent: Sunday, July 3, 2022 10:34 AM To: Connelly, Bill <BConnelly@buttecounty.net>; Lucero, Debra <DLucero@buttecounty.net>; Kimmelshue, Tod <TKimmelshue@buttecounty.net>; Ritter, Tami <TRitter@buttecounty.net>; District Attorney <District_Attorney@buttecounty.net>; Waugh, Melanie <mwaugh@buttecounty.net>; Teeter, Doug <DTeeter@buttecounty.net>; Clerk of the Board <clerkoftheboard@buttecounty.net> Subject: New Comirnaty labeled “vaccine” .ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening attachments, clicking on links, or replying.. This just passed! Please be aware of what is happening now! "They” have a new “vaccine” they are labeling as Comirnaty but it’s NOT Comirnaty! Comirnaty is approved. I falsely stated it doesn’t exist. I made a mistake. I made a correction and included lot numbers. It DOES exist; however, people can’t find it. I was with a friend who said she would be vaccinated by Comirnaty. The vaccinator tried to tell her that the two “vaccines” are interchangeable but they are NOT! One is approved and the other one is NOT approved. I’m sure they will be using this technique with this new Comirnaty labeled “vaccine”. PLEASE BE AWARE!!!! REASON: They desperately want these “vaccines” on the Pediatric Schedule so they can get protected from the 1986 Injury Compensation Act and are no longer under EUA making it an approved shot. This way NO ONE can refuse it. This is the level of deception we are having to deal with. diana Sent from my iPad